269 related articles for article (PubMed ID: 22527657)
1. Role of HMGB1 in doxorubicin-induced myocardial apoptosis and its regulation pathway.
Yao Y; Xu X; Zhang G; Zhang Y; Qian W; Rui T
Basic Res Cardiol; 2012 May; 107(3):267. PubMed ID: 22527657
[TBL] [Abstract][Full Text] [Related]
2. The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway.
Xu H; Su Z; Wu J; Yang M; Penninger JM; Martin CM; Kvietys PR; Rui T
J Immunol; 2010 Feb; 184(3):1492-8. PubMed ID: 20028656
[TBL] [Abstract][Full Text] [Related]
3. Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-α/JNK.
Xu H; Yao Y; Su Z; Yang Y; Kao R; Martin CM; Rui T
Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H913-21. PubMed ID: 21186276
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-33 attenuates doxorubicin-induced cardiomyocyte apoptosis through suppression of ASK1/JNK signaling pathway.
Yao Y; Chen R; Ying C; Zhang G; Rui T; Tao A
Biochem Biophys Res Commun; 2017 Nov; 493(3):1288-1295. PubMed ID: 28965952
[TBL] [Abstract][Full Text] [Related]
5. HMGB1: the missing link between diabetes mellitus and heart failure.
Volz HC; Seidel C; Laohachewin D; Kaya Z; Müller OJ; Pleger ST; Lasitschka F; Bianchi ME; Remppis A; Bierhaus A; Katus HA; Andrassy M
Basic Res Cardiol; 2010 Nov; 105(6):805-20. PubMed ID: 20703492
[TBL] [Abstract][Full Text] [Related]
6. The HMGB1-TLR4 axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte apoptosis.
Ding HS; Yang J; Chen P; Yang J; Bo SQ; Ding JW; Yu QQ
Gene; 2013 Sep; 527(1):389-93. PubMed ID: 23727604
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
[TBL] [Abstract][Full Text] [Related]
8. High-mobility group box-1 protein induces osteogenic phenotype changes in aortic valve interstitial cells.
Wang B; Li F; Zhang C; Wei G; Liao P; Dong N
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):255-62. PubMed ID: 26515875
[TBL] [Abstract][Full Text] [Related]
9. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.
Mukhopadhyay P; Rajesh M; Bátkai S; Kashiwaya Y; Haskó G; Liaudet L; Szabó C; Pacher P
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1466-83. PubMed ID: 19286953
[TBL] [Abstract][Full Text] [Related]
10. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
[TBL] [Abstract][Full Text] [Related]
11. High-mobility group box 1-mediated heat shock protein beta 1 expression attenuates mitochondrial dysfunction and apoptosis.
Narumi T; Shishido T; Otaki Y; Kadowaki S; Honda Y; Funayama A; Honda S; Hasegawa H; Kinoshita D; Yokoyama M; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Watanabe T; Tanaka A; Woo CH; Abe J; Takeishi Y; Kubota I
J Mol Cell Cardiol; 2015 May; 82():1-12. PubMed ID: 25736854
[TBL] [Abstract][Full Text] [Related]
12. [Blocking extracellular HMGB1 activity protects against doxorubicin induced cardiac injury in mice].
Ma YG; Zhang XW; Bao HY; Yu SS; Hu ZW; Sun W
Yao Xue Xue Bao; 2012 Nov; 47(11):1489-95. PubMed ID: 23387082
[TBL] [Abstract][Full Text] [Related]
13. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
14. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
[TBL] [Abstract][Full Text] [Related]
15. Hmgb1-TLR4-IL-23-IL-17A axis promote ischemia-reperfusion injury in a cardiac transplantation model.
Zhu H; Li J; Wang S; Liu K; Wang L; Huang L
Transplantation; 2013 Jun; 95(12):1448-54. PubMed ID: 23677049
[TBL] [Abstract][Full Text] [Related]
16. Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes.
Yamamoto Y; Hoshino Y; Ito T; Nariai T; Mohri T; Obana M; Hayata N; Uozumi Y; Maeda M; Fujio Y; Azuma J
Cardiovasc Res; 2008 Jul; 79(1):89-96. PubMed ID: 18346979
[TBL] [Abstract][Full Text] [Related]
17. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
[TBL] [Abstract][Full Text] [Related]
18. Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling.
Herzog C; Lorenz A; Gillmann HJ; Chowdhury A; Larmann J; Harendza T; Echtermeyer F; Müller M; Schmitz M; Stypmann J; Seidler DG; Damm M; Stehr SN; Koch T; Wollert KC; Conway EM; Theilmeier G
Cardiovasc Res; 2014 Mar; 101(3):400-10. PubMed ID: 24323314
[TBL] [Abstract][Full Text] [Related]
19. Salvianolic acid B attenuates doxorubicin-induced ER stress by inhibiting TRPC3 and TRPC6 mediated Ca
Chen RC; Sun GB; Ye JX; Wang J; Zhang MD; Sun XB
Toxicol Lett; 2017 Jul; 276():21-30. PubMed ID: 28495616
[TBL] [Abstract][Full Text] [Related]
20. HMGB1 Neutralizing Antibody Attenuates Cardiac Injury and Apoptosis Induced by Hemorrhagic Shock/Resuscitation in Rats.
Zhou Y; Li Y; Mu T
Biol Pharm Bull; 2015; 38(8):1150-60. PubMed ID: 26040987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
